Kiniksa Pharmaceuticals Chairman and CEO Sanj K Patel reports $14.33 million share sale
KNSA•Kiniksa Pharmaceuticals Chairman and CEO Sanj K. Patel sold 151,300 Class A ordinary shares for prices ranging from $92.35 to $96.05 per share on November 4, 2026, and exercised options for 145,763 shares at $17.92 each.
1. Share transactions
Patel sold 151,300 Class A ordinary shares on November 4, 2026, at reported prices ranging from $92.35 to $96.05 per share. He also exercised options for 145,763 Class A ordinary shares at $17.92 per share. Following the transactions, he indirectly held 976,643 Class A ordinary shares through three trusts.
